Treatment Outcome of Patients with Laryngeal Cancer

We conducted a retrospective study of 90 cases of laryngeal cancer treated at our department between 2012 and 2021: the patients included 59 cases with the glottic type of cancer (stage I: 39 cases; stage II: 13 cases; stage III: 6 cases; stage IV: 1 case), 28 cases with the supraglottic type of cancer (stage I: 4 cases; stage II: 4 cases; stage III: 4 cases; stage IV: 16 cases), and 3 cases with the subglottic type of cancer (stage II: 1 case; stage IV: 2 cases). The 5-year overall survival rate was 90.2% in the patients with stage I–II disease (61 cases) and 61.3% in the patients with stage III–IV disease (29 cases). In the patients with stage III–IV disease, the poor prognostic factors were: serum albumin level less than 3.6 g/dL at initial diagnosis, neutrophil-to-lymphocyte ratio greater than 3.4, and body mass index less than 20.